Semler Scientific/$SMLR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Semler Scientific
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test. also invest in bitcoin and have adopted bitcoin as its treasury reserve asset. Company's healthcare technology solutions business is predominant operational focus, providing cash flows and enabling it to pursue bitcoin.
Ticker
$SMLR
Sector
Primary listing
Employees
79
Headquarters
Website
SMLR Metrics
BasicAdvanced
$406M
6.80
$3.94
1.40
-
Price and volume
Market cap
$406M
Beta
1.4
52-week high
$81.56
52-week low
$25.43
Average daily volume
1.2M
Financial strength
Current ratio
0.596
Quick ratio
0.444
Long term debt to equity
25.105
Total debt to equity
25.111
Interest coverage (TTM)
2.67%
Profitability
EBITDA (TTM)
5.254
Gross margin (TTM)
90.84%
Net profit margin (TTM)
86.20%
Operating margin (TTM)
12.10%
Effective tax rate (TTM)
17.02%
Revenue per employee (TTM)
$540,000
Management effectiveness
Return on assets (TTM)
1.07%
Return on equity (TTM)
16.04%
Valuation
Price to earnings (TTM)
6.804
Price to revenue (TTM)
5.675
Price to book
0.96
Price to tangible book (TTM)
0.96
Price to free cash flow (TTM)
20.026
Free cash flow yield (TTM)
4.99%
Free cash flow per share (TTM)
1.338
Growth
Revenue change (TTM)
-30.39%
Earnings per share change (TTM)
94.26%
3-year revenue growth (CAGR)
-7.54%
10-year revenue growth (CAGR)
25.44%
3-year earnings per share growth (CAGR)
34.48%
10-year earnings per share growth (CAGR)
13.39%
What the Analysts think about SMLR
Analyst ratings (Buy, Hold, Sell) for Semler Scientific stock.
Bulls say / Bears say
Semler Scientific agreed to be acquired by Strive, backed by Ramaswamy, in a $1.34 billion all-stock deal that values SMLR at $90.52 per share—a roughly 210% premium—highlighting substantial value creation for shareholders (Reuters).
In Q2 2025, Semler launched CardioVanta™, a wholly-owned subsidiary targeting early detection of heart failure and arrhythmia, expanding and strengthening its future healthcare growth prospects (PRNewswire).
Since April 15, 2025, Semler’s at-the-market equity program has raised about $39.8 million by selling over 1.1 million shares, supporting its Bitcoin treasury strategy without tapping operational cash (Nasdaq).
Core healthcare revenues fell 43% year-over-year to $8.2 million in Q2 2025, leading to an operating loss following unfavorable CMS reimbursement changes and putting pressure on the company’s traditional business model (Nasdaq).
Two customers made up 76% of Q2 2025 revenues, greatly increasing concentration risk and exposing Semler to significant revenue volatility if these clients change their usage (Nasdaq).
An SEC filing reveals a critical customer representing over 10% of revenue has stopped using QuantaFlo, and warns Q4 2025 revenues are expected to drop by at least 60% from Q3, suggesting further weakening in healthcare demand (Investing.com).
Data summarised monthly by Lightyear AI. Last updated on 4 Oct 2025.
SMLR Financial Performance
Revenues and expenses
SMLR Earnings Performance
Company profitability
SMLR News
AllArticlesVideos
Semler Scientific, Inc. INVESTOR ALERT: Kirby McInerney LLP Notifies Semler Scientific, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
Business Wire2 weeks ago
Semler Scientific, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SMLR
Business Wire3 weeks ago
SEMLER SCIENTIFIC INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Semler Scientific, Inc. - SMLR
Business Wire3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Semler Scientific stock?
Semler Scientific (SMLR) has a market cap of $406M as of October 12, 2025.
What is the P/E ratio for Semler Scientific stock?
The price to earnings (P/E) ratio for Semler Scientific (SMLR) stock is 6.8 as of October 12, 2025.
Does Semler Scientific stock pay dividends?
No, Semler Scientific (SMLR) stock does not pay dividends to its shareholders as of October 12, 2025.
When is the next Semler Scientific dividend payment date?
Semler Scientific (SMLR) stock does not pay dividends to its shareholders.
What is the beta indicator for Semler Scientific?
Semler Scientific (SMLR) has a beta rating of 1.4. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.